Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.

W W Hauck, S Anderson

    Journal of Pharmacokinetics and Biopharmaceutics
    |February 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Study of charmless hadronic B meson decays to pseudoscalar-vector final states.

    Physical review letters·2000
    Same author

    Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?

    Current hypertension reports·2000
    Same author

    Laparoscopic inguinal hernia repair: optimal technical variations and results in 1700 cases.

    The American surgeon·2000
    Same author

    New techniques in fast time-resolved structure determination.

    Cellular and molecular biology (Noisy-le-Grand, France)·2000
    Same author

    Patient desire and reasons for specialist referral in a gatekeeper-model managed care plan.

    The American journal of managed care·2000
    Same author

    Effects of estrogen on leukocyte adhesion after transient forebrain ischemia.

    Stroke·2000

    A new t-test procedure offers a more powerful way to test for equivalence in bioavailability trials. This statistical method improves upon traditional confidence interval approaches for drug development.

    Area of Science:

    • Pharmacokinetics and Pharmacodynamics
    • Biostatistics
    • Clinical Trial Design

    Background:

    • Comparative bioavailability trials are essential for drug development, ensuring therapeutic equivalence between drug products.
    • Current statistical methods for testing equivalence often rely on confidence intervals, which may lack optimal power.
    • The need for robust statistical hypothesis testing in regulatory submissions is critical.

    Purpose of the Study:

    • To restate the clinical problem of equivalence testing in comparative bioavailability trials using appropriate statistical hypotheses.
    • To introduce a novel, more powerful t-test procedure for assessing bioequivalence.
    • To provide guidance on sample size determination for this new procedure.

    Main Methods:

    • Formulation of statistical hypotheses specifically tailored for equivalence testing.

    Related Experiment Videos

  • Development and application of a simple t-test procedure.
  • Comparison of the proposed t-test with traditional confidence interval methods.
  • Inclusion of a practical example demonstrating the procedure and sample size calculation.

    • Main Results:

    • The proposed t-test procedure demonstrates superior statistical power compared to methods using shortest or symmetric confidence intervals.
    • The new method provides a more efficient approach to testing for bioequivalence.
    • The outlined sample size determination method ensures adequate power for the t-test.

    Conclusions:

    • The developed t-test procedure represents a statistically sound and more powerful alternative for equivalence testing in bioavailability studies.
    • This method enhances the precision and reliability of bioequivalence assessments.
    • Adoption of this procedure can lead to more efficient and informative clinical trials.